A study on liver cancer patients with percutaneous thermal ablation found that the peripheral blood of patients with early recurrence contained a high proportion of PD-1+CD4+ T cells and TIM-3+CD8+ T cells [35]. The gene discussed is CD8A; the disease is liver cancer.